CBM Financial Facts

Income/(loss) from discontinued operations, net of tax: -0.14
Research and development expenses: 3.19M
See Full Income Statement

Cash and cash equivalents: 90.74M
Other non-current liabilities: 22.2M
See Full Balance Sheet

Cambrex Corp. (CBM) Earnings

  |   Expand Research on CBM
Next EPS Date 2/8/17 *Est. EPS Growth Rate +17.5% *Last Qtr.
Average EPS % Beat Rate +0.1% Revenue Growth Rate +7.4% *Last Qtr.
Average % Move 1-Wk after EPS +9.1% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
11/4/16 Q316 $0.47$0.41 +$0.06$99.9M$96.07M N/A Details
7/28/16 Q216 $0.68$0.59 +$0.09$119.1M$114.85M N/A Details
4/28/16 Q116 N/A$0.34 N/A N/A$83.61M N/A N/A N/A
2/9/16 Q415 $0.54$0.83 -$0.29$156.9M$152.94M N/A Details
11/3/15 Q315 $0.40$0.38 +$0.02$92.98M$101.09M Details
7/30/15 Q215 $0.63$0.44 +$0.19$106.4M$110.03M Details
5/1/15 Q115 $0.29$0.23 +$0.06$78.2M$76.01M Details
2/6/15 Q414 $0.64$0.50 +$0.14$128.8M$117.9M Details